Pharmetric Laboratory’s rapid microbiology testing leverages ATP Bioluminescence technology to accelerate the detection of microbiological contaminants in compounded sterile preparations (CSPs). This method measures adenosine triphosphate (ATP) released from cells, converting it into visible light using the luciferin–luciferase reaction. Using a specially formulated, validated reagent, Pharmetric ensures light is generated consistently over a significant time window, creating reliable, repeatable testing protocols. Once the reagent interacts with the sample, a highly sensitive luminometer captures and processes the resulting fluorescent data. The outcome? Actionable results within days, compared to the weeks required by traditional culture-based compendial methods.
The benefits extend well beyond speed. Rapid ATP Bioluminescence testing allows pharmacies to optimize workflow and inventory management while safeguarding compliance. Faster results mean the product can be released sooner, supporting better inventory turnover and reducing costly waste. For sterile compounding operations, this translates into more responsive patient care, reduced financial risk from quarantined product, and the ability to respond quickly to quality concerns. Pharmetric’s full suite of microbiological testing services includes:
- ATP Bioluminescence Testing, rapid microbial detection within days
- Compendial (USP <71>) Sterility Testing, established gold-standard validation
- Endotoxin (USP <85>) Testing, ensuring patient safety through pyrogen detection
In short, Pharmetric’s approach offers a blend of speed, accuracy, and compliance that directly impacts operational efficiency and patient safety. By embracing rapid microbiology methods, pharmacies can achieve significant cost savings, increased inventory turns, less waste, and enhanced revenue streams while reinforcing their commitment to delivering the highest quality compounded sterile preparations.
